Similar articles for PMID: 27139251

Year	Number of Results
1997	1
1998	2
2001	1
2002	2
2003	2
2004	1
2005	4
2006	1
2007	4
2008	2
2010	1
2011	4
2012	3
2013	7
2014	3
2015	9
2016	5
2017	4
2018	4
2019	3
2020	3
2021	6
2022	2
2024	0

1

Synthesis and amylin receptor activity of glycomimetics of pramlintide using click chemistry.

Yule LR, Bower RL, Kaur H, Kowalczyk R, Hay DL, Brimble MA. Yule LR, et al. Org Biomol Chem. 2016 Jun 21;14(23):5238-45. doi: 10.1039/c6ob00850j. Epub 2016 May 3. Org Biomol Chem. 2016. PMID: 27139251

2

Convergent chemoenzymatic synthesis of a library of glycosylated analogues of pramlintide: structure-activity relationships for amylin receptor agonism.

Kowalczyk R, Brimble MA, Tomabechi Y, Fairbanks AJ, Fletcher M, Hay DL. Kowalczyk R, et al. Org Biomol Chem. 2014 Nov 7;12(41):8142-51. doi: 10.1039/c4ob01208a. Epub 2014 Jul 17. Org Biomol Chem. 2014. PMID: 25030939

3

Activity of pramlintide, rat and human amylin but not Aβ1-42 at human amylin receptors.

Gingell JJ, Burns ER, Hay DL. Gingell JJ, et al. Endocrinology. 2014 Jan;155(1):21-6. doi: 10.1210/en.2013-1658. Epub 2013 Dec 20. Endocrinology. 2014. PMID: 24169554

4

Amylin structure-function relationships and receptor pharmacology: implications for amylin mimetic drug development.

Bower RL, Hay DL. Bower RL, et al. Br J Pharmacol. 2016 Jun;173(12):1883-98. doi: 10.1111/bph.13496. Epub 2016 May 18. Br J Pharmacol. 2016. PMID: 27061187 Free PMC article. Review.

5

Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition.

Adler BL, Yarchoan M, Hwang HM, Louneva N, Blair JA, Palm R, Smith MA, Lee HG, Arnold SE, Casadesus G. Adler BL, et al. Neurobiol Aging. 2014 Apr;35(4):793-801. doi: 10.1016/j.neurobiolaging.2013.10.076. Epub 2013 Oct 11. Neurobiol Aging. 2014. PMID: 24239383

6

Amylin.

Hay DL. Hay DL. Headache. 2017 May;57 Suppl 2:89-96. doi: 10.1111/head.13077. Headache. 2017. PMID: 28485843 Review.

7

Amyloidogenesis of the amylin analogue pramlintide.

da Silva DC, Fontes GN, Erthal LC, Lima LM. da Silva DC, et al. Biophys Chem. 2016 Dec;219:1-8. doi: 10.1016/j.bpc.2016.09.007. Epub 2016 Sep 20. Biophys Chem. 2016. PMID: 27665170

8

Development of Cagrilintide, a Long-Acting Amylin Analogue.

Kruse T, Hansen JL, Dahl K, Schäffer L, Sensfuss U, Poulsen C, Schlein M, Hansen AMK, Jeppesen CB, Dornonville de la Cour C, Clausen TR, Johansson E, Fulle S, Skyggebjerg RB, Raun K. Kruse T, et al. J Med Chem. 2021 Aug 12;64(15):11183-11194. doi: 10.1021/acs.jmedchem.1c00565. Epub 2021 Jul 21. J Med Chem. 2021. PMID: 34288673 Free article.

9

Physico-chemical properties of co-formulated fast-acting insulin with pramlintide.

da Silva DC, Lima LMTR. da Silva DC, et al. Int J Pharm. 2018 Aug 25;547(1-2):621-629. doi: 10.1016/j.ijpharm.2018.06.039. Epub 2018 Jun 19. Int J Pharm. 2018. PMID: 29928940

10

Copper(II) and Amylin Analogues: A Complicated Relationship.

Alghrably M, Dudek D, Emwas AH, Jaremko Ł, Jaremko M, Rowińska-Żyrek M. Alghrably M, et al. Inorg Chem. 2020 Feb 17;59(4):2527-2535. doi: 10.1021/acs.inorgchem.9b03498. Epub 2020 Feb 6. Inorg Chem. 2020. PMID: 32027132 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

69 results

Results by year